19:00 às 19:30 - BLOCO 3 - HIGHLIGHTS ESTADIO III e IV (imunoterapia)

19:15 às 19:20 - OA09.03 - Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC)